FRANKFURT (Reuters) - Fresenius Medical Care (DE:FMEG), the world's largest provider of kidney dialysis, posted a 2 percent gain in quarterly operating profit, missing consensus, as growth in the number of dialysis patients was offset by higher personnel expenses and other costs.
Second-quarter earnings before interest and tax came in at 583 million euros ($690 million), below the average estimate of 611 million euros from a Reuters poll of analysts.
The group still expects 2017 adjusted net income to increase by 7-9 percent at constant currencies.
($1 = 0.8453 euros)